Studies on the modification of the live AIK measles vaccine. II. Development and evaluation of the live AIK-C measles vaccine. 1974

S Makino, and K Sasaki, and N Nakamura, and M Nakagawa, and S Nakajima

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D008459 Measles virus The type species of MORBILLIVIRUS and the cause of the highly infectious human disease MEASLES, which affects mostly children. Edmonston virus
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

S Makino, and K Sasaki, and N Nakamura, and M Nakagawa, and S Nakajima
June 1974, The Kitasato archives of experimental medicine,
S Makino, and K Sasaki, and N Nakamura, and M Nakagawa, and S Nakajima
January 1983, Reviews of infectious diseases,
S Makino, and K Sasaki, and N Nakamura, and M Nakagawa, and S Nakajima
April 1973, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
S Makino, and K Sasaki, and N Nakamura, and M Nakagawa, and S Nakajima
April 1975, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
S Makino, and K Sasaki, and N Nakamura, and M Nakagawa, and S Nakajima
March 2020, Vaccines,
S Makino, and K Sasaki, and N Nakamura, and M Nakagawa, and S Nakajima
January 2016, Vaccine,
S Makino, and K Sasaki, and N Nakamura, and M Nakagawa, and S Nakajima
May 1966, Kumamoto Igakkai zasshi. The Journal of the Kumamoto Medical Society,
S Makino, and K Sasaki, and N Nakamura, and M Nakagawa, and S Nakajima
January 1964, Annales paediatrici. International review of pediatrics,
S Makino, and K Sasaki, and N Nakamura, and M Nakagawa, and S Nakajima
July 2019, Vaccine,
S Makino, and K Sasaki, and N Nakamura, and M Nakagawa, and S Nakajima
February 2006, Vaccine,
Copied contents to your clipboard!